Memantine for disruptive behavior in autistic disorder - PubMed (original) (raw)

Case Reports

Memantine for disruptive behavior in autistic disorder

Craig A Erickson et al. J Clin Psychiatry. 2006 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• Managing disruptive and compulsive behaviors in adult with autistic disorder with gabapentin.
  Guglielmo R, Ioime L, Grandinetti P, Janiri L. Guglielmo R, et al. J Clin Psychopharmacol. 2013 Apr;33(2):273-4. doi: 10.1097/JCP.0b013e318285680c. J Clin Psychopharmacol. 2013. PMID: 23422383 No abstract available.
• Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.
  Niederhofer H. Niederhofer H. J Clin Psychopharmacol. 2007 Jun;27(3):317-8. doi: 10.1097/01.jcp.0000270082.30500.69. J Clin Psychopharmacol. 2007. PMID: 17502791 Clinical Trial. No abstract available.
• Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors.
  Kapetanovic S. Kapetanovic S. Am J Psychiatry. 2007 May;164(5):832-3. doi: 10.1176/ajp.2007.164.5.832. Am J Psychiatry. 2007. PMID: 17475749 No abstract available.
• [Psychopharmacology of autistic disorders].
  Poustka L, Poustka F. Poustka L, et al. Z Kinder Jugendpsychiatr Psychother. 2007 Mar;35(2):87-94. doi: 10.1024/1422-4917.35.2.87. Z Kinder Jugendpsychiatr Psychother. 2007. PMID: 17608278 Review. German.
• Memantine for dementia?
  [No authors listed] [No authors listed] Drug Ther Bull. 2003 Oct;41(10):73-6. Drug Ther Bull. 2003. PMID: 14593973 Review.

Cited by

• A retrospective study of memantine in children and adolescents with pervasive developmental disorders.
  Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ. Erickson CA, et al. Psychopharmacology (Berl). 2007 Mar;191(1):141-7. doi: 10.1007/s00213-006-0518-9. Epub 2006 Oct 3. Psychopharmacology (Berl). 2007. PMID: 17016714
• Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.
  Doyle CA, McDougle CJ. Doyle CA, et al. Dialogues Clin Neurosci. 2012 Sep;14(3):263-79. doi: 10.31887/DCNS.2012.14.3/cdoyle. Dialogues Clin Neurosci. 2012. PMID: 23226952 Free PMC article. Review.
• TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.
  Gürkan CK, Hagerman RJ. Gürkan CK, et al. Res Autism Spectr Disord. 2012 Oct 1;6(4):1311-1320. doi: 10.1016/j.rasd.2012.05.007. Res Autism Spectr Disord. 2012. PMID: 23162607 Free PMC article.
• A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
  Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, Frazier TW, Tirouvanziam R. Hardan AY, et al. Biol Psychiatry. 2012 Jun 1;71(11):956-61. doi: 10.1016/j.biopsych.2012.01.014. Epub 2012 Feb 18. Biol Psychiatry. 2012. PMID: 22342106 Free PMC article. Clinical Trial.
• Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.
  Ghanizadeh A. Ghanizadeh A. Neurochem Res. 2011 May;36(5):922-3. doi: 10.1007/s11064-010-0381-2. Epub 2011 Jan 6. Neurochem Res. 2011. PMID: 21210221

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database